Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V J Hruby

Showing results (431-440 of 504) with videos related to

Pageof 51
Sort By:
Journal of Neurochemistry|June 15, 2000
Assessment of stereoselectivity of trimethylphenylalanine analogues of delta-opioid [D-Pen(2),D-Pen(5)]-enkephalinK A Witt, C A Slate, R D Egleton, et al.
The Journal of Investigative Dermatology|September 1, 1987
Stimulation of follicular melanogenesis in the mouse by topical and injected melanotropinsN Levine, A Lemus-Wilson, S H Wood, et al.
The Journal of Endocrinology|January 1, 1981
Racemization effects on melanocyte-stimulating hormones and related peptidesA M Bool, G H Gray, M E Hadley, et al.
Biopolymers|February 1, 1996
Exploration of the conformational space of oxytocin and arginine-vasopressin using the electrostatically driven Monte Carlo and molecular dynamics methodsA Liwo, A Tempczyk, S Ołdziej, et al.
Pharmaceutical Biotechnology|October 7, 1998
Discovery and development of novel melanogenic drugs. Melanotan-I and -IIM E Hadley, V J Hruby, J Blanchard, et al.
Molecular and Cellular Endocrinology|July 1, 1985
Stimulation of S91 melanoma tyrosinase activity by superpotent alpha-melanotropinsM M Marwan, Z A Abdel Malek, K L Kreutzfeld, et al.
Journal of Medicinal Chemistry|September 27, 1996
The use of topographical constraints in receptor mapping: investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe-NH2 (SNF 9007), a cholecystokinin (26-33) analogue that binds to both CCK-B and delta-opioid receptorsL W Boteju, G V Nikiforovich, C Haskell-Luevano, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1996
Human delta opioid receptor: functional studies on stably transfected Chinese hamster ovary cells after acute and chronic treatment with the selective nonpeptidic agonist SNC-80E Malatynska, Y Wang, R J Knapp, et al.
Journal of Medicinal Chemistry|July 21, 1998
Structure-function studies on positions 17, 18, and 21 replacement analogues of glucagon: the importance of charged residues and salt bridges in glucagon biological activityN S Sturm, Y Lin, S K Burley, et al.
Peptides|March 1, 1990
Alpha-melanocyte stimulating hormone message and inhibitory sequences: comparative structure-activity studies on melanocytesT K Sawyer, D J Staples, A M Castrucci, et al.
Pageof 51

Showing results (431-440 of 504) with videos related to

Sort By:
Pageof 51
Journal of Neurochemistry|June 15, 2000
Assessment of stereoselectivity of trimethylphenylalanine analogues of delta-opioid [D-Pen(2),D-Pen(5)]-enkephalinK A Witt, C A Slate, R D Egleton, et al.
The Journal of Investigative Dermatology|September 1, 1987
Stimulation of follicular melanogenesis in the mouse by topical and injected melanotropinsN Levine, A Lemus-Wilson, S H Wood, et al.
The Journal of Endocrinology|January 1, 1981
Racemization effects on melanocyte-stimulating hormones and related peptidesA M Bool, G H Gray, M E Hadley, et al.
Biopolymers|February 1, 1996
Exploration of the conformational space of oxytocin and arginine-vasopressin using the electrostatically driven Monte Carlo and molecular dynamics methodsA Liwo, A Tempczyk, S Ołdziej, et al.
Pharmaceutical Biotechnology|October 7, 1998
Discovery and development of novel melanogenic drugs. Melanotan-I and -IIM E Hadley, V J Hruby, J Blanchard, et al.
Molecular and Cellular Endocrinology|July 1, 1985
Stimulation of S91 melanoma tyrosinase activity by superpotent alpha-melanotropinsM M Marwan, Z A Abdel Malek, K L Kreutzfeld, et al.
Journal of Medicinal Chemistry|September 27, 1996
The use of topographical constraints in receptor mapping: investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe-NH2 (SNF 9007), a cholecystokinin (26-33) analogue that binds to both CCK-B and delta-opioid receptorsL W Boteju, G V Nikiforovich, C Haskell-Luevano, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1996
Human delta opioid receptor: functional studies on stably transfected Chinese hamster ovary cells after acute and chronic treatment with the selective nonpeptidic agonist SNC-80E Malatynska, Y Wang, R J Knapp, et al.
Journal of Medicinal Chemistry|July 21, 1998
Structure-function studies on positions 17, 18, and 21 replacement analogues of glucagon: the importance of charged residues and salt bridges in glucagon biological activityN S Sturm, Y Lin, S K Burley, et al.
Peptides|March 1, 1990
Alpha-melanocyte stimulating hormone message and inhibitory sequences: comparative structure-activity studies on melanocytesT K Sawyer, D J Staples, A M Castrucci, et al.
Pageof 51